ACAD
38.04
+0.26
+0.69%
AEMD
0.2
-0.01
-5.50%
APRI
2.22
-0.12
-5.33%
ARNA
4.49
-0.26
-5.47%
ATEC
1.44
+0.09
+6.67%
CFN
60.09
-0.13
-0.21%
CNAT
6.36
-0.1
-1.55%
CRXM
0.21
+0.00
+0.05%
CYTX
1.17
+0.04
+3.54%
DXCM
60.71
-1.25
-2.02%
GNMK
12.8
-0.1
-0.78%
HALO
15.07
-0.21
-1.37%
ILMN
195.5
-2.96
-1.49%
INNV
0.15
-0.02
-8.83%
INO
7.09
+0.06
+0.85%
ISCO
0.06
0.00
0.00%
ISIS
68.49
+1.16
+1.72%
LGND
55.22
-0.6
-1.07%
LPTN
2.95
-0.04
-1.34%
MBVX
0.91
0.00
0.00%
MEIP
5.88
-0.11
-1.76%
MNOV
3.55
-0.05
-1.39%
MRTX
23.73
-0.24
-1.00%
MSTX
0.52
-0.02
-4.37%
NBIX
39.11
-0.94
-2.35%
NUVA
45.86
+0.87
+1.93%
ONCS
0.37
+0.00
+0.24%
ONVO
5.95
-0.11
-1.82%
OREX
5.62
-0.25
-4.26%
OTIC
36.63
+0.71
+1.98%
QDEL
25.77
-0.24
-0.92%
RCPT
126.81
+0.3
+0.24%
RGLS
18.56
-0.74
-3.83%
RMD
64.45
+0.21
+0.32%
SCIE
0.03
+0.00
+14.58%
SPHS
0.79
+0.3
+60.20%
SRNE
12.9
-0.36
-2.74%
TROV
5.66
+0.12
+2.17%
VICL
1
-0.01
-0.99%
VOLC
17.99
0.00
0.00%
ZGNX
1.68
+0.03
+1.82%
Home » Archive by Category

Syndication

Quality Associate (Sorrento Valley)

February 25, 2015 – 5:15 pm

Outstanding Clinical Packaging company seeks candidate to support packaging, labeling and shipping operations. This position will focus in the QC inspection of packaging and labeling operations, and incoming materials inspection activities. In additi […

Packaging Operator (Sorrento Valley)

February 25, 2015 – 5:14 pm

Outstanding Clinical Packaging company seeks candidate to be responsible for producing finished packaged and/or labeled clinical product (including kits) for company clients as per batch instructions while following the principles of cGMP practices. […

Aethlon Medical Announces First Patient Completes Hemopurifier Clinical Study Protocol

February 25, 2015 – 5:00 pm

SAN DIEGO, Feb. 26, 2015 /PRNewswire/ –Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, today announced that the first patient enrolled in the Company’s FDA approved …

Breg Promotes <b>Brad Lee</b> To President And CEO

February 25, 2015 – 5:00 pm

CARLSBAD, Calif., Feb. 25, 2015 /PRNewswire/ –Breg, Inc., a premier provider of sports medicine products and services, announced today that its board of directors has promoted Brad Lee to president and chief executive…

Fate Therapeutics To Present At Cowen and Company 35th Annual Health Care Conference

February 25, 2015 – 5:00 pm

SAN DIEGO, Feb. 25, 2015 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life-threatening diseases, today announced that …

Otonomy, Inc. Submits New Drug Application To The FDA For Auripro

February 25, 2015 – 5:00 pm

SAN DIEGO, Feb. 26, 2015 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear, tod…

Receptos To Hold Fourth Quarter And Year End 2014 Financial Results Conference Call

February 25, 2015 – 5:00 pm

SAN DIEGO, Feb. 26, 2015 (GLOBE NEWSWIRE) — Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, will review financial results for the fourth quarter and year e…

MediciNova, Inc.’s MN-001 (Tipelukast) NASH With Advanced Fibrosis Abstract Accepted For Presentation At The American Association for Study of Liver Diseases And Industry Colloquium: Novel Targets And Therapies In Liver Disease In Durham, North Carolina

February 25, 2015 – 5:00 pm

LA JOLLA, Calif., Feb. 25, 2015 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that it has been in…

Senomyx, Inc. Announces Fourth Quarter And Full Year 2014 Financial Results

February 25, 2015 – 5:00 pm

SAN DIEGO, Feb. 26, 2015 /PRNewswire/ –Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply…

Epic Sciences To Present At 35th Annual Cowen and Company Health Care Conference

February 25, 2015 – 5:00 pm

SAN DIEGO, Feb. 26, 2015 /PRNewswire/ –Epic Sciences announced today that President and CEO Murali Prahalad, Ph.D. will present at the 35th Annual Cowen and Company Health Care Conference onWednesday, March 4, 2015at10:00 a.m. EST in the MIT Room, 3rd…